NORDICENDOTROPHIN
Dead / Abandoned — Abandoned — failure to respond (as of 27 Oct 2025)
What this means for you
This application is over — abandoned 14 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79405513
- Mark type
- Stylized text
- Filed
- 23 Aug 2024
- Abandoned
- 14 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.
- Class 042 — Scientific and technological services: Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.
Owner
Prosecution history
- 19 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 02 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 02 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 27 Oct 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 27 Oct 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 04 May 2025 — REFUSAL PROCESSED BY IB
- 12 Apr 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 12 Apr 2025 — REFUSAL PROCESSED BY MPU
- 07 Mar 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 06 Mar 2025 — NON-FINAL ACTION WRITTEN
- 27 Feb 2025 — ASSIGNED TO EXAMINER
- 08 Oct 2024 — APPLICATION FILING RECEIPT MAILED
- 08 Oct 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Oct 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB